205 related articles for article (PubMed ID: 34535767)
21. Psychomotor changes in major depressive disorder during sertraline treatment.
Schrijvers D; Maas YJ; Pier MP; Madani Y; Hulstijn W; Sabbe BG
Neuropsychobiology; 2009; 59(1):34-42. PubMed ID: 19270462
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
Weinberger JF; Raison CL; Rye DB; Montague AR; Woolwine BJ; Felger JC; Haroon E; Miller AH
Brain Behav Immun; 2015 Jul; 47():193-200. PubMed ID: 25529904
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
Sukhram SD; Yilmaz G; Gu J
Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
[TBL] [Abstract][Full Text] [Related]
24. Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder.
Beheydt LL; Schrijvers D; Docx L; Bouckaert F; Hulstijn W; Sabbe B
J Affect Disord; 2015 Dec; 188():47-52. PubMed ID: 26342888
[TBL] [Abstract][Full Text] [Related]
25. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
[TBL] [Abstract][Full Text] [Related]
26. Retardation in depression: assessment by means of simple motor tasks.
Sabbe B; Hulstijn W; van Hoof J; Tuynman-Qua HG; Zitman F
J Affect Disord; 1999 Sep; 55(1):39-44. PubMed ID: 10512604
[TBL] [Abstract][Full Text] [Related]
27. The nature of the relationship of psychomotor slowing with negative symptomatology in schizophrenia.
Bervoets C; Docx L; Sabbe B; Vermeylen S; Van Den Bossche MJ; Morsel A; Morrens M
Cogn Neuropsychiatry; 2014; 19(1):36-46. PubMed ID: 23725330
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory and interferon gene expression signatures in patients with mitochondrial disease.
Warren EB; Gordon-Lipkin EM; Cheung F; Chen J; Mukherjee A; Apps R; Tsang JS; Jetmore J; Schlein ML; Kruk S; Lei Y; West AP; McGuire PJ
J Transl Med; 2023 May; 21(1):331. PubMed ID: 37208779
[TBL] [Abstract][Full Text] [Related]
29. [Psychomotor retardation in depression assessed by visuomotor tasks. Overview and achievements of ten years' research].
Pier MP; Hulstijn W; van Hoof JJ; Sabbe BG
Tijdschr Psychiatr; 2006; 48(2):95-106. PubMed ID: 16958193
[TBL] [Abstract][Full Text] [Related]
30. Action monitoring in major depressive disorder with psychomotor retardation.
Schrijvers D; de Bruijn ER; Maas Y; De Grave C; Sabbe BG; Hulstijn W
Cortex; 2008 May; 44(5):569-79. PubMed ID: 18387589
[TBL] [Abstract][Full Text] [Related]
31. Acute inflammation and psychomotor slowing: Experimental assessment using lipopolysaccharide administration in healthy humans.
Handke A; Axelsson J; Benson S; Boy K; Weskamp V; Hasenberg T; Remy M; Hebebrand J; Föcker M; Brinkhoff A; Unteroberdörster M; Engler H; Schedlowski M; Lasselin J
Brain Behav Immun Health; 2020 Oct; 8():100130. PubMed ID: 34589881
[TBL] [Abstract][Full Text] [Related]
32. An altered peripheral IL6 response in major depressive disorder.
Money KM; Olah Z; Korade Z; Garbett KA; Shelton RC; Mirnics K
Neurobiol Dis; 2016 May; 89():46-54. PubMed ID: 26804030
[TBL] [Abstract][Full Text] [Related]
33. The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.
Felger JC
Curr Top Behav Neurosci; 2017; 31():199-219. PubMed ID: 27225499
[TBL] [Abstract][Full Text] [Related]
34. No psychomotor slowing in fine motor tasks in dysthymia.
Pier MP; Hulstijn W; Sabbe BG
J Affect Disord; 2004 Dec; 83(2-3):109-20. PubMed ID: 15555703
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia.
van Hoof JJ; Jogems-Kosterman BJ; Sabbe BG; Zitman FG; Hulstijn W
J Psychiatr Res; 1998; 32(2):99-103. PubMed ID: 9694005
[TBL] [Abstract][Full Text] [Related]
36. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia.
Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
Neurotox Res; 2018 Feb; 33(2):448-460. PubMed ID: 29103192
[TBL] [Abstract][Full Text] [Related]
37. Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression.
Hickie I; Ward P; Scott E; Haindl W; Walker B; Dixon J; Turner K
Psychiatry Res; 1999 Dec; 92(2-3):75-81. PubMed ID: 10674361
[TBL] [Abstract][Full Text] [Related]
38. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
39. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia.
Haroon E; Chen X; Li Z; Patel T; Woolwine BJ; Hu XP; Felger JC; Miller AH
Transl Psychiatry; 2018 Sep; 8(1):189. PubMed ID: 30202011
[TBL] [Abstract][Full Text] [Related]
40. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study.
Rogers D; Lees AJ; Smith E; Trimble M; Stern GM
Brain; 1987 Jun; 110 ( Pt 3)():761-76. PubMed ID: 3107750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
